1000t/d含油废水旋流分离技术及设备研究

将实验室研制的 HL 型旋流器用压力容器式方式并联起来 ,建立 10 0 0 t/ d规模的示范装置 ,并进行试验。示范装置的试验结果表明 ,与工业测试比较 ,HL型旋流器并没有因为规模的放大而造成性能下降 ,它能取代石化行业目前采用的“一隔二浮”流程中的大部分装置 ,具有明显的经济效益和广阔的应用前景     

西山白家庄矿8煤可排放硫含量的测定

针对西山白家庄矿8煤的实际情况，初步尝试了测定其硫的实际排放状况，探索了温度及添加剂对可排放 硫含量的影响。结果表明该煤的自身固硫率不高； 添加9％的CaO可排放硫含量可以达到城市窑（锅）炉对硫分的要求；同时试验表明MgO对可排放硫影响不大。     

环境模型的统计评价

系统地探讨了评价模型的统计指标,并在BOD反应动力学模型中使用,取得了较好的效果。     

水环境中痕量有机有害物质的监测

论述了水中有机有害物质的监测,实质上是一项复杂系统的痕量分析课题。重点评述了痕量富集、色谱分离与监测、综合分析的主要进展。     

废水中对—氨基苯酚的电位溶出法测定

采用Nafion修饰电极,以微分计时电位溶出法分析测定废水中对—氨基苯酚(PAP)。在选定的条件下,PAP的测定范围在1.0μ～0.5mmol/l之间;最低检测浓度为0.1μmol/l;标准偏差为1.6％:方法的回收率为92.5％～96.5％。     

灰色模型在确定关键污染因子中的应用

将灰色模型引入水环境质量评价中 ,通过对某个时间段内污染物原始监测数据的灰色处理 ,从动态演变中找出关键因子 ,客观地判定各污染因子所起的作用 ,并对各因子在下一个时间段的发展趋势作出判断 ,增加了评价的准确性。经过实例运用分析表明 ,该方法物理意义明确 ,简便易用     

高效液相色谱-串联质谱法同时测定地表水中33种药物

采用固相萃取-高效液相色谱-串联质谱法(SPE-HPLC-MS/MS)建立了地表水中25种抗生素类药物和8种非抗生素类药物的分析方法。通过重点优化质谱参数、色谱条件、样品pH、洗脱溶剂组成及用量等确定了最佳分析条件。水样经过滤、固相萃取柱富集净化后,选择Shim-pack XR-ODS为色谱柱,以乙腈和0.2%甲酸-2 mmol/L乙酸铵-水溶液为流动相进行梯度洗脱,采用电喷雾电离源,在多反应监测模式下(MRM)分析测定,内标法定量。33种药物的仪器定量限为0.012～4.68 ng/L,方法检出限为0.011～7.60 ng/L,地表水加标回收率为53.7%～122%,相对标准偏差为1.22%～32.1%(n=6)。方法成功应用于北京市凉水河12个地表水样分析,共检出32种药物,检出质量浓度为未检出～239 ng/L。利托那韦(RTV)作为新型冠状病毒诊疗方案中推荐的药物在凉水河检出率为100%。     

超声破解污泥上清液对A~2O工艺脱氮除磷和微生物群落结构的影响

为了提高传统污水处理工艺的脱氮除磷效率、实现污泥资源化,本实验通过超声破解污泥获取碳源,采用耗氧呼吸速率分析上清液作为碳源的可行性,并将上清液回用于生活污水,考察其对A2O工艺长期运行的脱氮除磷效果和微生物群落结构的影响。结果表明,上清液中可降解有机物达到76.2%,具有作为内碳源的潜能;上清液和生活污水按1∶15投入A2O反应器后,氮、磷的去除率分别从63.2%和53.4%提高到了82.1%和94.7%;上清液明显改变了微生物群落结构,使除磷菌Actinobacteia和反硝化聚磷菌Sphingobacterium富集。     

Manganese concentrations in maternal–infant blood and birth weight

Manganese (Mn) is an essential mineral nutrient in mammals. The physiological role of Mn in animal models is well documented, but little is known about the adverse effects of Mn deficiency or overexposure in humans, including pregnancy outcomes such as birth weight. We examined the relationship of the maternal and cord blood Mn levels with birth weight in a cohort of 172 mother–infant pairs born in Shanghai, China. Non-linear spline and quadratic regression models were used to test the hypothesis of an inverted U-shaped association between the Mn levels and birth weight. The median (range) levels of Mn in the maternal and cord blood were 5.38 (2.34–30.37) μg/dL and 7.66 (2.57–34.23) μg/dL, respectively. An inverted U-shaped relationship was observed between maternal Mn and birth weight after adjusting for potential confounders. The birth weight increased with Mn levels up to 4.18 μg/dL, and a slight reduction in weight was observed at higher levels. The cord blood Mn levels were not found to be associated with birth weight. Both lower and higher Mn exposures are associated with lower birth weight, which may influence important developmental parameters; the association of higher Mn levels with lower weight was weak and imprecise.